DANNIELL HICKS: Open Payments
NPI 1649847583 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,555 in 95 payments from 29 companies in 2025. Trend: 2023 $1,148 · 2024 $1,773 · 2025 $2,555
Food & beverage: $2,555
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $534 |
| Insulet Corporation | 23 | $451 |
| Xeris Pharmaceuticals, Inc. | 5 | $215 |
| Lilly USA, LLC | 8 | $158 |
| Phathom Pharmaceuticals, Inc. | 3 | $147 |
| ViiV Healthcare Company | 1 | $122 |
| Dexcom, Inc. | 1 | $95 |
| UCB, Inc. | 4 | $94 |
| Verona Pharma, Inc. | 5 | $94 |
| Actelion Pharmaceuticals US, Inc. | 1 | $90 |
Products named: Omnipod, Ozempic, VOQUEZNA, GVOKE HYPOPEN, MOUNJARO, Wegovy, CABENUVA, DEXCOM G7 GSS (161).
Industry payments across DE — which companies pay providers there.
